Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FUICS is a specialized biotechnology and technology company based in Japan that focuses on the development and commercialization of advanced microfluidic chip systems for life science research. The company's core business revolves around providing high-precision fluidic solutions that enable sophisticated cell culture, drug screening, and diagnostic applications. By leveraging its proprietary microfluidic technology, FUICS supports pharmaceutical companies and academic institutions in optimizing drug discovery workflows and developing next-generation cell-based assays. Their products are designed to mimic physiological environments more accurately than traditional methods, facilitating more reliable preclinical data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuics Development.